ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB177

Factors Associated with Adherence to Antihypertensive Treatment and Complications Due to Inadequate Adherence in Patients Undergoing Hemodialysis at the Hospital Regional Puebla ISSSTE

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Pérez Reyes, Sergio Victor, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Perez Reyes, Alexis, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Gonzalez Farris, Maria Jose, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Hernandez, Kriscia Mariela, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Gálvez-Romero, José L., Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Lima, Brenda, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
Background

Poor medication adherence hampers hypertension control and increases the risk of adverse health outcomes. Medication adherence can be measured with direct and indirect methods.In México not exist any study to evaluate the medication adherence in patiens under hemodialysis.For this is important to assess Mexican hypertensive patients’ adherence rate to hypertension therapeutic regimen and to identify the strongest predictors of adherence rate among such patients.

Methods

A descriptive comparison design and convenience sampling were used. The sample comprised 113 participants who came to their regular sessions at hemodialysis in a ISSSTE hospital. The Hill-Bone Compliance to High Blood Pressure Therapy Scale indirectly assesses adherence to hypertension therapy in three behavioral domains: appointment keeping, diet and medication adherence. Secondary objectives to evaluate if there is a relationship between adherence to treatment and years on hemodialysis, levels of urea, potassium, creatinine, albumin and ferritin.

Results

113 patients were evaluated, of which 54 were women and 59 men.The length of stay on hemodialysis was from 1 to 12 years. 89.4% have been on hemodialysis for less than 6 years.85.8% of patients obtained a good adherence result.14.2% of patients have moderate-poor adherence to antihypertensive treatment.We found that albumin levels above 3.5 g/dl were correlated with better adherence to pharmacological treatment (p ≤.0405).During the time of patient evaluation, 5 deaths were reported, all belonging to the group with poor adherence to pharmacological treatment.

Conclusion

This is the first study to be include hemodialysis patients in Mexico.Adherence to taking antihypertensive medications was good overall among the study participants; these participants, however, they agreed to have a high consumption of table salt and forget to take their medication at least once a week.The HBCHBPT Scale has high versatility globally and has been used in various settings by various healthcare worker cadres and researchers.The scale has several strengths, including high adherence phenotyping capabilities, contributing to the paradigm shift toward personalized health care,

Funding

  • Government Support – Non-U.S.